Pharmaceutical company GlaxoSmithKline has launched an online system giving researchers access to data from its clinical trials.
The patient-level data will be anonymous and available only to researchers who provide a scientific protocol for how they will use them. Researchers requesting access must also commit to publishing their findings.
Requests for access will be reviewed by an independent panel, comprising Brian Strom, a professor of public health and preventive medicine at the University of Pennsylvania; Marc Buyse, associate professor of biostatistics, Hasselt University, Belgium; Bartha Maria Knoppers, director of the Center of Genomics and Policy at McGill University, Canada; and John Hughes, patient and public involvement member of the UK Clinical Research Collaboration Board.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.